Carola Ries

Carola Ries

Company: Macomics

Job title: CSO


**TAM Depletion vs Reprogramming: Why Both Have Merit 3:29 pm

• Sharing lessons learned from depleting macrophages in cancer patients • Providing ipdates on clinical development of emactuzumab, aCSF1R blocking antibody that depletes tumor-associated macrophages (TAM) • Harnessing TAM heterogeneity to design novel TAM reprogramming agents **Unfortunately Carola is unable to join us in person, but her slides will be made available post-eventRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.